To evaluate the diagnostic accuracy of CD68-labeled macrophagic CLSs in discriminating MASH, we performed immunohistochemistry of CD68 in liver biopsies from all participants in the validation cohort and conducted ROC analysis. Here, CD68 is linked to metabolic dysfunction-associated steatohepatitis.